Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest Expense - DepositsInterest Expense - OthersInterest ExpensesInterest Income - Debt SecuritiesInterest Income - DepositsInterest Income - NetInterest Income - TotalInterest income - InvestmentsInterest income - LoansInvestment Banking IncomeInvestment Gain (Loss)Net Income towards Common StockholdersNon-Interest IncomeOperating ExpensesOperating IncomeOther Non-Interest IncomeOther Operating ExpensesProfit After TaxProvisionsResearch & DevelopmentRevenueShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

First Capital (FCAP) EBT (2016 - 2025)

First Capital has reported EBT over the past 10 years, most recently at -$13.5 million for Q4 2025.

  • Quarterly results put EBT at -$13.5 million for Q4 2025, down 22.49% from a year ago — trailing twelve months through Dec 2025 was -$10.5 million (up 10.17% YoY), and the annual figure for FY2025 was $19.9 million, up 40.45%.
  • EBT for Q4 2025 was -$13.5 million at First Capital, down from $1.8 million in the prior quarter.
  • Over the last five years, EBT for FCAP hit a ceiling of $3.7 million in Q4 2022 and a floor of -$13.5 million in Q4 2025.
  • Median EBT over the past 5 years was $1.5 million (2023), compared with a mean of $450100.0.
  • Biggest five-year swings in EBT: tumbled 2305.8% in 2024 and later soared 515.77% in 2025.
  • First Capital's EBT stood at $3.1 million in 2021, then rose by 19.01% to $3.7 million in 2022, then tumbled by 86.35% to $500000.0 in 2023, then tumbled by 2305.8% to -$11.0 million in 2024, then decreased by 22.49% to -$13.5 million in 2025.
  • The last three reported values for EBT were -$13.5 million (Q4 2025), $1.8 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.